Sr no. | Board of Directors | Designation |
1 | Dr. Naresh Trehan | Chairman & Managing Director |
2 | Mr. Pankaj Prakash Sahni | Group CEO & Director |
3 | Mr. Hari Shanker Bhartia | Non-Executive Independent Director |
4 | Ms. Praveen Mahajan | Non-Executive Independent Director |
5 | Mr. Rajan Bharti Mittal | Non-Executive Independent Director |
6 | Dr. Ravi Gupta | Non-Executive Independent Director |
7 | Mr. Ravi Kant Jaipuria | Non-Executive Nominee Director |
8 | Mr. Sunil Sachdeva | Non-Executive Director |
9 | Mr. Venkatesh R. | Non-Executive Nominee Director |
10 | Mr. Vikram Singh Mehta | Non-Executive Independent Director |
Total Bank Loan Facilities Rated | Rs. 500 Crore |
Short Term Rating | CRISIL A1+ (Reaffirmed) |
Long Term Rating | CRISIL A+ (Reaffirmed) |
CRISIL Report -19.09.2022 | Click here |
Registered Office:
Medanta-Mediclinic E-18,
Defence Colony
New Delhi-110024
Ph No.011- 44114411
Corporate Office:
Medanta – The Medicity,
Sector-31, Gurugram,
122001, Haryana
Phno: 124-414 1414
For Investor Grievances
Mr. Rahul Ranjan, Compliance Officer
Medanta – The Medicity,
Sector-31, Gurugram,122001, Haryana
Tel: 124 483 4060;
Email: : compliance@medanta.org
Registrar & Share Transfer Agent
KFin Technologies Private Limited
Selenium, Tower-B
Plot 31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareddi 500 032
Telangana, India
Tel: +91 40 6716 2222
E-mail: globalhealth.ipo@kfintech.com
Investor grievance e-mail: einward.ris@kfintech.com
Website: www.kfintech.com
SEBI Registration No.: INR000000221
Contact Details of Key Managerial Personnel Under Regulation 30(5) of the SEBI(Listing Obligations and Disclosure Requirements) Regulations, 2015
S. No | Name & Designation | Email address | Contact Number |
1. | Dr. Naresh Trehan, Chairman & Managing Director | Naresh.Trehan@Medanta.org | Tel: +91 124 483 4060 |
2. | Mr. Pankaj Sahni, Group Chief Executive Officer | Pankaj.Sahni@Medanta.org |
Sr no. | Name of the Members | Designation |
1 | Mr. Ravi Gupta, Independent Director | Chairman |
2 | Ms. Praveen Mahajan, Independent Director | Member |
3 | Mr. Venkatesh Ratnasami, Non-Executive Director | Member |
Sr no. | Name of Committee Members | Category |
1 | Mr. Vikram Mehta, Independent Director | Chairperson |
2 | Ms. Praveen Mahajan, Independent Director | Member |
3 | Mr. Rajan Bharti Mittal, Independent Director | Member |
4 | Dr. Naresh Trehan, Chairman & Managing Director | Member |
Sr no. | Name of Committee Members | Category |
1 | Dr. Naresh Trehan, Chairman & Managing Director | Chairperson |
2 | Mr. Sunil Sachdeva, Non-Executive Director | Member |
3 | Mr. Rajan Bharti Mittal, Independent Director | Member |
4 | Mr. Vikram Singh Mehta, Independent Director | Member |
Sr no. | Name of Committee Members | Category |
1 | Dr. Ravi Gupta, Independent Director | Chairperson |
2 | Ms. Praveen Mahajan, Independent Director | Member |
3 | Mr. Pankaj Sahni, CEO | Member |
Sr no. | Name of Committee Members | Category |
1 | Dr. Ravi Gupta, Independent Director | Chairperson |
2 | Mr. Ravi Jaipuria, Non-Executive Director | Member |
3 | Mr. Rajan Bharti Mittal, Independent Director | Member |
4 | Mr. Hari Shanker Bhartia, Independent Director | Member |
B.3_Fresh COI dated 11.08.2021
B.4_BR_Authorising Offer_17.09.2021
B.5_Shareholder Resolution_Authorising Offer_21.09.2021
B.6_BR Approving DRHP_29.09.2021
B.7_BR Approving Addendum to DRHP
B.8_BR and Shareholders Approval for Modification in OFS
B.9_BR_RHP Approval_22.10.2022
B.10_CTC- Prospectus Approval-November 9 2022
B.11_Consent Letter of Investor Selling Shareholder_11 10 2021
B.12 Share Purchase Agreement_13052017
B.13_Scheme of amalgamation and merger of NTAHS with Co
B.16_RJ Corp_ Investment Agreeement_Suppl Agreement and Undertaking
B.17_Agreement dated 13 05 2017_ Dr NT and SS
B.19_Agreement for CCPS Conversion_04.01.2022
B.20_Trademark License Agreement Amendment Agreements and Waiver Letters
B.21_Resolutions for appoinment of Dr NT as CMD
B.22_Resolutions for appoinmnet of Dr NT as Chaiman-Heart Institute and CCS
B.23_ BR dated July 25 2022 _Re appoinment of Dr NT as CMD
B.25_CA Examniation Report_02 09 22
B.26_Special tax Benefit Report_14 10 2022 (1)
B.27_Assessment of of the healthcare delivery market in India _26 09 2022
B.28_Consent for Assessment of Health Delivery Market_26 09 2022_CRSIL
B.29_Engagement Letter of CRISIl_15 09 22
B.31_Consent of CA to Include their name
B.32_Consent of RM Marwah CA to Include their name
B.33_Triparty Agreement btw Co CDSl Registrar_09 09 2021
B.34_Triparty Agreement btw Co NSDl Registrar_09 04 2021
B.35_DD Certificate_29 09 2021
Schedule Of Analyst/Institutional Investor Meet Dated ; 16 December 22
Schedule Of Analyst/Institutional Investor Meet Dated ; 15 December 22
Schedule Of Analyst/Institutional Investor Meet Dated ; 12 December 22
Schedule Of Analyst/Institutional Investor Meet Dated ; 05 December 22
Schedule Of Analyst/Institutional Investor Meet Dated ; 29 November 22
Schedule Of Analyst/Institutional Investor Meet Dated ; 29 November 22
Schedule Of Analyst/Institutional Investor Meet Dated ; 28 November 22
Schedule Of Analyst/Institutional Investor Meet Dated ; 22 November 22